Celik, SebahattinKiziltan, RemziYilmaz, Eyup M.Yilmaz, OzkanDemir, Halit2025-05-102025-05-1020171752-03631752-037110.2217/bmm-2016-03672-s2.0-85016758520https://doi.org/10.2217/bmm-2016-0367https://hdl.handle.net/20.500.14720/11924Yilmaz, Ozkan/0000-0001-7320-0722Aim: Plasma prolidase activities (PPAs) in cases of gastric cancer. Methodology/results: This study was based on a prospective design. 60 patients with gastric cancer (operable cases: 48; inoperable: 12) and 60 healthy controls were included in the study. Prolidase activity was analyzed. The mean PPA levels in the operable, inoperable and control groups were 45.60 +/- 4.20, 54.35 +/- 4. 9 and 10.92 +/- 0.79 U/l, respectively (p < 0.001). PPA decreased significantly after tumor resection. PPA level was significant in differentiating operable cases from inoperable (sensitivity: 91.7%; specificity: 85.2%). Discussion/conclusion: PPA was significantly higher in patients with inoperable gastric cancer than in operable cases and the control group. A strong correlation was found between tumor volume and PPA.eninfo:eu-repo/semantics/closedAccessEnzymesGastric CancerPrognostic FactorsProlidase ActivityTumor MarkersArticle114Q4Q331932728150509WOS:000401945400003